基于指标的药品辅助剂潜在供应风险评估:方法和应用
Kosuke Nemoto1, Yusuke Hayashi1, Hirokazu Sugiyama1
1Department of Chemical System Engineering, The University of Tokyo, Tokyo, Japan.
这项研究使用Herfindahl-Hirschman指数 (HHI) 评估了日本的制药辅助剂供应风险. 酸,药片和囊具有最高的风险,需要多元化等减轻风险的策略.
科学领域:
- 制药科学 制药科学
- 供应链管理 供应链管理
- 风险评估 风险评估
背景情况:
- 药物辅助剂对于药物配方和输送至关重要.
- 确保辅助剂的稳定供应链对于公共卫生至关重要.
- 市场集中可能会导致严重的供应风险.
研究的目的:
- 开发和应用基于指标的系统来评估制药辅助剂供应风险.
- 在日本市场中识别高风险的辅助剂,剂型和疾病类别.
- 为减轻已识别的供应风险提供可行的建议.
主要方法:
- 系统调查,数据收集和指标值计算.
- 调整赫芬达尔-希尔施曼指数 (HHI) 用于市场度分析.
- 用于风险评估的化合物,剂型和疾病水平的案例研究.
主要成果:
- 乙酸因其广泛使用和市场度被确定为高风险化合物.
- 药片和囊显示与颗粒相比,供应风险更高,突出显示需要剂型多样化.
- 成人疾病药物供应链可能是脆弱的,因为依赖于药片配方.
结论:
- 基于指标的评估有效地确定了制药辅助剂供应的弱点.
- 助剂和剂型的多样化对于供应链的弹性至关重要.
- 建议从高风险配方,如成人疾病的药片,进行战略性转变.
更多相关视频
06:12Using Multiple Light Scattering to Examine the Stability of Phyllanthus emblica L. Extracts Obtained with Different Extraction Methods
Published on: April 14, 2023
08:06Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays
Published on: November 10, 2016
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioequivalence: Overview
Analysis of Population Pharmacokinetic Data
Biopharmaceutics and Pharmacokinetics: Overview
